Nurix Therapeutics, Inc. ($NRIX)
Filing Information
| Accession Number | 0001817217-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 30, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
19,604
Total Value
$39,748.98
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Apr 30, 2026 | Exercise/Conversion | 2,000 | $0.00 | $0.00 | 47,427 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Apr 30, 2026 | Exercise/Conversion | 3,750 | $0.00 | $0.00 | 51,177 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Apr 30, 2026 | Exercise/Conversion | 2,858 | $0.00 | $0.00 | 54,035 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Apr 30, 2026 | Sale | 2,388 | $16.65 | $39,748.98 | 51,647 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Units | Derivative | Apr 30, 2026 | Exercise/Conversion | 2,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Units | Derivative | Apr 30, 2026 | Exercise/Conversion | 3,750 | $0.00 | $0.00 | 15,000 | Direct | โ | View Details | |
Chief Financial Officer | Restricted Stock Units | Derivative | Apr 30, 2026 | Exercise/Conversion | 2,858 | $0.00 | $0.00 | 22,867 | Direct | โ | View Details |